Validation of processes in pharmaceutical industry

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Validation of processes in pharmaceutical industry

3rd International Conference on Pharmaceutical Regulatory Affairs

October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Mereyim Bouslikhane

Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Government, pharmacists, physicians, patients and health insurance companies are interested in safe and efficient product and asking value for money; the reason that pharmaceutical companies have the obligation to validate their processes to meet GMP requirements. The validation is a fundamental part of regulatory requirements for almost every process in the global health industry (Pharmaceuticals, biologics and medical devices); it is a key component in assuring that the quality targets are met. This presentation will give a general overview on the validation activities and highlight its impact on the pharmaceutical industry to ensure that systems, services and products directly influenced by the testing have been identified.

Biography :

Mereyim Bouslikhane Holds a Ph.D. in organic chemistry from the University of Paul Sabatier in France and completed a postdoctoral in the field of anti-diabetics molecules synthesis. She has experience in Quality and Regulatory Affairs for the GCC, Levant, Africa & CIS countries and currently involved in validation activities at Neopharma, Abu Dhabi, United Arab Emirates.

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward